NCT03151538 is a NA clinical trial of Exercise Training Mixed With Play in Pes Planus, sponsored by Burcu Talu.

Who is sponsoring NCT03151538?

NCT03151538 is sponsored by Burcu Talu.

What drugs are being tested in NCT03151538?

Interventions in NCT03151538: Exercise Training Mixed With Play, Controlled.

What condition does NCT03151538 study?

NCT03151538 studies Pes Planus, Flat Foot, Femoral Anteversion.

Is NCT03151538 still recruiting?

NCT03151538 is currently completed. Last updated 18 August 2017.

Last reviewed 2017-08-18 · How we verify

NCT03151538

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects on Pes Planus Exercise Training Mixed With Play on Pre-school Children

Completed NA Last updated 18 August 2017

What this trial tests

NA trial testing Exercise Training Mixed With Play in Pes Planus in 90 participants. Completed in 14 June 2017.

Timeline

19 April 2017

Primary endpoint
7 June 2017

14 June 2017

Quick facts

Lead sponsor	Burcu Talu
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	90
Start date	19 April 2017
Primary completion	7 June 2017
Estimated completion	14 June 2017
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Exercise Training Mixed With Play
Controlled

Conditions studied

Pes Planus — all drugs for Pes Planus →
Flat Foot — all drugs for Flat Foot →
Femoral Anteversion — all drugs for Femoral Anteversion →

Sponsor

Burcu Talu

Who can join

Adults 4 to 7, any sex, with Pes Planus or Flat Foot. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study was planned to assess effects on pes planus and femoral anteversion angle of exercise training mixed with play on pre-school children.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Foot orthoses for treating paediatric flat feet.
Evans AM, Rome K, Carroll M, Hawke F. · · 2022 · cited 21× · PMID 35029841 · DOI 10.1002/14651858.cd006311.pub3
Foot orthoses for treating paediatric flat feet.
Evans AM, Rome K, Carroll M, Hawke F. · · 2022 · cited 6× · PMID 35080267 · DOI 10.1002/14651858.cd006311.pub4

Verify or expand the search:

Other recruiting trials for Pes Planus

Currently open trials in the same condition.

NCT07294014 — Investigation of Medial Longitudinal Arch and Foot Function in Patients With Lipedema · recruiting
NCT07286773 — Biofeedback-Assisted Short Foot Exercises in Flexible Flatfoot · NA · recruiting
NCT07000838 — Efficacy of Corrective Rubber Insoles in Healthcare Professionals With Foot Overpronation · NA · recruiting
NCT06491212 — The Relationship Between Pes Planus, Diaphragm, Postural Control, and Plantar Pressure · NA · recruiting
NCT06034600 — Effect of Augmented Low-dye* Taping and Exercise on Plantar Pressure, Navicular Drop and Foot Posture in Pes Planus · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03151538 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Burcu Talu
Last refreshed: 18 August 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03151538.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing